Study objective -To establish an updated prevalence and incidence figure for mul-
Setting -The Cambridge Health District of East Anglia covering 340 910 hectares in area and a population of 290 700. Patients -Altogether 441 patients prevalent on 1 July 1993 were identified, of whom 328 were contacted so that clinical data could be collected. Seventy patients (16%) either declined to take part or access was denied by their general practitioner; 8 (2%) had died; and 35 (8%) were too ill or failed to respond to several requests for contact.
Main results -A comprehensive re-evaluation of the south Cambridgeshire multiple sclerosis register revealed a prevalence of 441/290 700 population (152/ 105) for all disease classifications on 1 July 1993. This represented an increase of 18% from 1990 and was a result of 138 additions and 71 deletions from the original list of 374 patients. The sex ratio of prevalent patients was 2-6 F:M, the mean age at disease onset was 31'7 years, and the mean age was 49 years. Mortality for 1990-93 was 3-3/105Iyear and prospective maintenance of an incidence register recorded 96 new diagnoses for all classifications ofmultiple sclerosis over the five year period 1990-94 (6 6/105/year). Conclusions -The increase in prevalence mainly resulted from improved case ascertainment identifying a further 58 patients who had been prevalent in 1990. Comparisons with other serial studies within the United Kingdom show similarities in proportional increase with successive studies indicating that serial survey may in part account for the observed latitudinal gradient within the United Kingdom. However, the observed prevalence (152/105) in this second survey still falls short ofthe figure estimated from incidence and mortality data (186/105). The relatively few epidemiological studies of multiple sclerosis which have maintained large population based registers and provide the opportunity for serial measurements ofprevalence have been especially influential in generating hypotheses for causation of the disease. -3 In particular, studies in north east Scotland recorded the highest known prevalence and spawned the observation of a latitudinal gradient for the disease. The existence of this gradient seems indisputable; however, despite extensive investigation no environmental agent which explains this phenomenon has been incriminated. With increasing evidence of a genetic contribution to disease aetiology, it is of considerable importance to establish whether this gradient exists between or within genetically homogenous populations, or alternatively is an artefact of enhanced ascertainment resulting from serial estimations of prevalence in defined areas.
The Cambridgeshire register of patients with multiple sclerosis was established in 1989 and presented prevalence data from the Cambridge Health District on July 1 1990,4 demonstrating a combined disease prevalence of 130/105 for suspected and probable/definite multiple sclerosis in this previously unsurveyed population. The register has since been maintained and incidence data have been collected prospectively since January 1990. A comprehensive re-evaluation of the population was undertaken on July 1 1993 in order to identify patients missed in the initial study, to establish a new prevalence rate, and to report five year incidence and mortality data for the period 1990-94. These statistics have allowed us to assess the extent to which epidemiological surveys underestimate the prevalence rate expected from incidence and mortality data. The status of all 374 patients prevalent in 1990 was re-evaluated. Most were still prevalent, but some had died or moved out of the study area. In a few the diagnosis of multiple sclerosis had been refuted and a number of patients with suspected multiple sclerosis had changed diagnostic category. In addition, all new diagnoses of multiple sclerosis made by Cambridge based neurologists were used to derive incidence figures over a five year period from January 1990 to December 1994, after categorising patients according on whether they were newly diagnosed, had moved into the study area, or were prevalent in July 1990 but not ascertained.
Results
The provisional register contained 662 patients from all sources. Every general practice responded to the request to participate in the study; but two elected not to provide lists of patients because of concerns regarding confidentiality. A total of 194 patients on the provisional register had either died, moved away from the area, were duplicate referrals, or an alternative diagnosis had been established, and these were all excluded. After further clinical evaluation based on a personal interview or review of existing medical records, the diagnosis could not be confirmed in a further 27 individuals. The final register therefore comprised 441 patients with multiple sclerosis who were alive and prevalent within the study area on the 1 July 1993. The largest source of ascertainment was from departmental notes, which identified 368 (83%) of the prevalent patients. General practitioner referrals accounted for 225 (51%), the Multiple Sclerosis Society for 8 (2%), and nursing homes 13 -(3%). Ofthe 255 patients notified from a single source, 199 (45%) were derived from departmental notes, 53 (12%) from general (2) (3) (4) (5) (6) 145) had either probable or definite disease and (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) 61 (21/105; 95%CI 16, 27) suspected disease.
(138-167) Figure 1 shows the age and sex specific pre- valence of multiple sclerosis in the Cambridge (26- been included in the 1990 study, this would have increased the prevalence to 150/1i05 at that time. Only a small component of the new figure can therefore be attributed to an increase in incidence over the same period. We therefore believe that the most recent figure represents more accurately the true prevalence rate in south Cambridgeshire.
The effects of population migration within the study area may also partly account for the observed increase in ascertainment. Twenty nine patients prevalent in 1990 had left the area compared with eight who had moved in, representing a net emigration of 21 individuals. Population instability might be expected in an area where the major demographic centre is a university city. Temporary residents may remain registered with general practitioners outside the area, resulting in a time lag before local medical services become aware of their presence, particularly those with mild disease. Alternatively the disproportionately large cohort of young people may artificially inflate prevalence as a whole.
Prevalence is the product of incidence and disease duration and will alter with variation in either. Significant changes in incidence over time have been recorded in north east Scotland2 and the Orkney'9 and Shetland Islands,13 and these changes have been attributed to alterations in environmental exposure. However, the recorded incidence of disease may also be influenced by improved diagnostic facilities and techniques, and by local changes in clinical practice and diagnostic categorisation. These variations in methodology have plagued direct comparison of prevalence studies conducted at different times. The relationship ofincidence to prevalence in a chronic disease such as multiple sclerosis is difficult to interpret without the benefit of long term studies of incidence which monitor temporal change, especially since disease duration and hence prevalence are influenced by treatments which improve management of disease complications.
Studies of incidence and mortality are likely to be the most reliable method of predicting future epidemiological patterns of disease. These provide evidence for changes in aetiological risk factors with time and are useful in planning the distribution of health care resources. It is also important to know the true prevalence for the study area, assuming stable incidence, disease duration, and population structure. Since the mean duration of disease in our population calculated from prevalence and mortality data is 28-2 years, the estimated prevalence is 186/1 05. The 1990 study yielded 70% (130/105) and this has increased in the most recent survey to 82% (152/105). An estimated 18% therefore remain to be ascertained; clearly some individuals have only trivial manifestations of disease and are yet to. present to a physician. Concerns about confidentiality and reluctance to notify patients with suspected and mild disease will also contribute to incomplete ascertainment. Patients who tend to be overlooked also include those moving in and out of areas where population dynamics are poorly documented. Our figures In table 2 we have listed data for contemporary incidence figures within the United Kingdom and estimated prevalence from disease duration. Two classes of information exist; firstly, the more robust one derived from prospective registers recorded by neurologists working from a regional centre or, in the case of the Orkney and Shetlands, by the chief medical officer, and secondly, data derived from retrospective age of onset information collected in cross sectional studies, which have uniformly employed multiple ascertainment sources similar to this study. The similarities of recent estimates for incidence and prevalence irrespective of latitude and despite persistent differences in observed prevalence, suggest that there is more uniform distribution of multiple sclerosis than has hitherto been assumed.
Clearly 28 Taken as a whole these observations bring into question the presence of a direct relationship between disease frequency and latitude within the United Kingdom, where the disease gradient has until recently been considered to be the steepest in the world.
